Baudax Bio, Inc.
BXRXQ
$0.00
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -7.16M | -34.43M | -34.58M | -58.80M | -20.11M |
| Total Depreciation and Amortization | 175.00K | 53.00K | 67.00K | 78.00K | 83.00K |
| Total Amortization of Deferred Charges | 65.00K | 65.00K | 65.00K | 65.00K | 644.00K |
| Total Other Non-Cash Items | -11.06M | 17.02M | 8.14M | 29.58M | -18.57M |
| Change in Net Operating Assets | 3.67M | 1.51M | 357.00K | 1.28M | 1.30M |
| Cash from Operations | -14.31M | -15.78M | -25.96M | -27.79M | -36.66M |
| Capital Expenditure | -21.00K | 0.00 | 0.00 | 0.00 | -127.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 142.00K | 142.00K | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | -20.00K | -20.00K | 10.13M |
| Cash from Investing | 121.00K | 142.00K | -20.00K | -40.00K | 9.98M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.18M | -5.47M | -3.34M | -2.24M | -1.11M |
| Issuance of Common Stock | 14.58M | 17.91M | 16.09M | 20.83M | 19.87M |
| Repurchase of Common Stock | 0.00 | -1.00K | -1.00K | -3.00K | -26.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -496.00K | -602.00K | -1.41M | -1.41M | -1.20M |
| Cash from Financing | 8.90M | 11.85M | 11.33M | 17.18M | 17.53M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 6.93M | 0.00 | 0.00 |
| Net Change in Cash | -5.28M | -3.79M | -7.72M | -10.63M | -9.13M |